Breaking News

Arran Chemical Company Completes Stage II of its Strategic Plan ADAPT

The company has completed a multi-million Euro expansion of its manufacturing capacity and deployment of next ...

Biogen and Samsung Bioepis launch Imraldi in Europe

The product is the third anti-TNF biosimilar developed by Samsung Bioepis to be commercialised by Biogen across Europe

SPI Pharma launches Mannogem XL mannitol

Enabling the production of difficult-to-compress and problematic formulations

Preparing PIs for post EU-FMD success

Ian Haynes of Excellis Europe explains how the company’s unique approach to enabling collaboration between parallel ...

ACG group rebrands under single new identity

The integrated pharma manufacturing group consolidates its portfolio of businesses and regional brands into four ...

Almac Group expands existing North Carolina facility

The CDMO has invested in its clinical services and diagnostic service capabilities

Serialisation and data connectivity: Part I

The new wrinkle in your supply chain

PCI announces new facility dedicated to clinical trial returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the return of ...

CPhI Worldwide announces winners of fifteenth Pharma Awards

The full list of winners from the annual 2018 CPhI Pharma Awards has been released

The Falsified Medicines Directive: clarification for wholesalers, distributors and logistics partners

The Falsified Medicines Directive (FMD) 2011/62/EU comes into force on 9 February 2019

A grandmaster’s approach to successful tableting

Tableting is a fundamental unit operation in the production of pharmaceutical oral solid dosage forms. Despite its long ...

Why risk it? FMD is not going away! Are you ready?

The Falsified Medicines Directive (FMD) imposes strict serialisation requirements on pharmaceutical manufacturers, ...

Staying secure in the smart era

Three rules for cyber security

Merck offers rhabdovirus-free insect platform for viral vaccines and gene therapy development

This will be the first non-mammalian cell line in Merck’s cell culture portfolio, allowing customers worldwide access ...

In Brief

People

Reports

Discover, learn and connect at Lab Innovations!

Pharmacovigilance in the hands of patients

ATP detection: The balance between precision and speed

Making a difference in pharma contract manufacturing

Continuously driving pharmaceutical manufacturing efficiencies

The rise of independent excipients

Making the case for the strategic outsourcing of serialisation

Partnerships, business and growth at CPhI 2018 Madrid

Preventing downtime in pharmaceuticals

The importance of high-quality compressed air in manufacturing

How does the EU shape up to its transpondian neighbours?

The era of pharma and biotech outsourcing is here to stay

Collagen scaffold production: The freeze drying method

Digitisation as a driver of product development

A sticky situation for medical device manufacturers

The increasing importance of drug-nutrient interactions